Hey respert 24, I kind of read the tea leaves w
Post# of 148179
(Total Views: 602)
Posted On: 12/14/2021 5:22:19 PM
Hey respert 24,
I kind of read the tea leaves with a grain of salt. Partnership? My question is can they advance leronlimab? Or is it something that they want to use in concert with whatever product they have? I understand they have a product that they want to use, but is leronlimab going to enhance their product or replace their product? If it's replacing their product then why bother?
On the subject of a buyout, for some reason I just don't see it because as you stated, hard to justify a value of a drug that touches on so many indications. Especially for one company IE big Pharma.
That's me just throwing stuff at the wall lol and I wish the drinking lamp was lit for me tonight unfortunately off to work I go!
I kind of read the tea leaves with a grain of salt. Partnership? My question is can they advance leronlimab? Or is it something that they want to use in concert with whatever product they have? I understand they have a product that they want to use, but is leronlimab going to enhance their product or replace their product? If it's replacing their product then why bother?
On the subject of a buyout, for some reason I just don't see it because as you stated, hard to justify a value of a drug that touches on so many indications. Especially for one company IE big Pharma.
That's me just throwing stuff at the wall lol and I wish the drinking lamp was lit for me tonight unfortunately off to work I go!
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼